Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The study aims to evaluate the safety and clinical effect of daily oral treatment with laquinimod capsules (0.5mg /day and 1mg /day) in active lupus arthritis patients. Laquinimod is a novel immunomodulating drug which is currently in advanced stages of development by Teva Pharmaceuticals Ltd. For Multiple Sclerosis.
Critère d'inclusion
- Lupus Arthritis